MDMA and parkinsonism [6]

New England Journal of Medicine

Volumn 349, Issue 1, 2003, Pages 96-97

  Kuniyoshi, Sandra M ^a   Jankovic, Joseph ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; CARBIDOPA PLUS LEVODOPA; SELEGILINE; TRIHEXYPHENIDYL;

ADULT; CASE REPORT; DOPAMINERGIC NERVE CELL; FAMILY HISTORY; HUMAN; LETTER; MALE; NEUROTOXICITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSON DISEASE; PARKINSONISM; PRIORITY JOURNAL; SEROTONINERGIC NERVE CELL; TREMOR; CHEMICALLY INDUCED DISORDER;

ADULT; HUMANS; MALE; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; PARKINSON DISEASE, SECONDARY;

EID: 0038167768     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJMc030208     Document Type: Letter

References (5)

1. Ricaurte GA, Yuan J, Hatzidimitriou G, Cord BJ, McCann UD. Severe dopaminergic neurotoxicity in primates after a common recreational dose regimen of MDMA ("ecstasy"). Science 2002;297:2260-3.
2. Mintzer S, Hickenbottom S, Gilman S. Parkinsonism after taking ecstasy. N Engl J Med 1999;340:1443.
3. Borg GJ. More about parkinsonism after taking ecstasy. N Engl J Med 1999;341:1400.
4. Baggott M, Mendelson J, Jones R. More about parkinsonism after taking ecstasy. N Engl J Med 1999;341:1400-1.
5. Sewell RA, Cozzi NV. More about parkinsonism after taking ecstasy. N Engl J Med 1999;341:1400.